Abbott Receives FDA Approval For Epic Max Tissue Valve

March 30, 2023 – Abbott has received U.S. Food and Drug Administration (FDA) has approval for its Epic™ Max stented tissue valve to treat people with aortic regurgitation or stenosis. This device is the latest addition to Abbott’s Epic surgical valve platform.

Abbott says that the Epic Max is designed to achieve excellent hemodynamics, or blood flow, and its low-profile frame facilitates potential future transcatheter interventions for patients. This new valve is built on the Epic surgical valve platform, leveraging its long-term performance and durability. 

Learn More